相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Correlates of Fatigability in Patients With Spinal Muscular Atrophy
Bart Bartels et al.
NEUROLOGY (2021)
Current status and development of anti-PD-1/PD-L1 immunotherapy for lung cancer
Luyao Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Incidence and characteristics of neurotoxicity in immune checkpoint inhibitors with focus on neuromuscular events: Experience beyond the clinical trials
Jordi Bruna et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2020)
Neurologic autoimmunity and immune checkpoint inhibitors
Elia Sechi et al.
NEUROLOGY (2020)
Neurological complications of chimeric antigen receptor T cells and immune-checkpoint inhibitors: ongoing challenges in daily practice
Giulia Berzero et al.
CURRENT OPINION IN ONCOLOGY (2020)
Treatment Considerations for Patients with Unresectable Metastatic Melanoma Who Develop Pembrolizumab-Induced Guillain-Barre Toxicity: A Case Report
Sivraj Muralikrishnan et al.
CASE REPORTS IN ONCOLOGY (2020)
Neuromuscular adverse events associated with anti-PD-1 monoclonal antibodies Systematic review
Annette Johansen et al.
NEUROLOGY (2019)
Immunotherapy in metastatic melanoma: a novel scenario of new toxicities and their management
Ester Simeone et al.
MELANOMA MANAGEMENT (2019)
Neurologic complications of immune checkpoint inhibitors
Avi Fellner et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Guillain-Barre-like syndrome during pembrolizumab treatment
Stephanie Ong et al.
MUSCLE & NERVE (2018)
Vasculitic neuropathy induced by pembrolizumab
F. Aya et al.
ANNALS OF ONCOLOGY (2017)
Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature
S. Cuzzubbo et al.
EUROPEAN JOURNAL OF CANCER (2017)
Inflammatory Myopathy and Axonal Neuropathy in a Patient With Melanoma Following Pembrolizumab Treatment
Panagiotis T. Diamantopoulos et al.
JOURNAL OF IMMUNOTHERAPY (2017)
Motor polyradiculopathy during pembrolizumab treatment of metastatic melanoma
Maria Sepulveda et al.
MUSCLE & NERVE (2017)
FACIAL DIPLEGIA AFTER PEMBROLIZUMAB TREATMENT
Micah D. Yost et al.
MUSCLE & NERVE (2017)
Neurological Complications Associated With Anti-Programmed Death 1 (PD-1) Antibodies
Justin C. Kao et al.
JAMA NEUROLOGY (2017)
Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy
Lisa Zimmer et al.
EUROPEAN JOURNAL OF CANCER (2016)
Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy
Marie-Florence de Maleissye et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
分享论文
